At CD BioGlyco, we have experts in the field of Pharmaceutical Excipient Analysis and have developed a pharmaceutical analysis team to provide quality xanthan gum analysis services to our clients worldwide. Xanthan gum is a biopolymer polysaccharide derived from the fermentation of sugar by Xanthomonas spp. microorganisms, with good viscosity and excellent rheological properties, non-toxic and non-pharmacological. Xanthan gum is also an excellent new excipient for pharmaceutical preparations, e.g. as a carrier for slow-release tablets.
Technology: Fourier transform infrared spectroscopy (FT-IR), Nuclear magnetic resonance (NMR), X-ray diffraction (XRD)
Journal: Biomolecules
IF: 5.5
Published: 2019
Results: In the present research, the authors have deeply analyzed the property characteristics of low molecular weight xanthan gum using FT-IR, NMR, XRD, etc. The experimental results showed that the monosaccharide composition of low molecular weight xanthan gum was mannose, glucose, and glucuronic acid (molar ratio of 1.5:1.63: 1.0), and the molecular weight was 4.07 × 104 Da. Through further antioxidant experiments, the authors found that xanthan gum had a good scavenging ability against hydroxyl radicals, superoxide anion, and DPPH radicals. On the other hand, xanthan gum also had a good protective effect on Caco-2 cells damaged by H2O2. The results of these experiments suggest that xanthan gum might be used in food or pharmaceuticals to mitigate and protect against oxidative damage caused by the overproduction of reactive oxygen species.
Fig.1 FT-IR of commercial xanthan and biodegradation product. (Hu, et al., 2019)
CD BioGlyco provides reliable xanthan gum analysis services according to clients' needs. If you have any questions about pharmaceutical excipient analysis please feel free to contact us and our staff will be happy to answer them.
Reference